Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer U.S. Commercial Division Revenues [legacy 2024–2025 by Year
U.S. Commercial Division Revenues [legacy 2024–2025 structure] ($M) ($M)
Pfizer U.S. Commercial Division Revenues [legacy 2024–2025: $36,708M in FY2025, down 4.2% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Note 17 Segment & Geographic Information.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Commercial Division Revenues [legacy 2024–2025 structure] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36,708 | -4.2% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 38,332 | +38.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 27,749 | -19.2% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 34,337 | – | Form 10-K (filed 2025-02-27) ↗ |
Breakdown
What makes up U.S. Commercial Division Revenues [legacy 2024–2025
Cite this data
StockData. (2026). Pfizer U.S. Commercial Division Revenues [legacy 2024–2025 ($M), annual FY2022–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/div-leg-us-comm
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.